Raz, Itamar
Hadassah Medical Center
33 papers on CoChatORCID 0000-0003-0209-4453
Most cited papers
- Verified
Guideline Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
Raz, I. (2013) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 71
- Verified
Changes in albuminuria predict cardiovascular and renal outcomes in type 2 diabetes: a post Hoc analysis of the LEADER trial
Persson, F., Bain, S. C., Mosenzon, O., Heerspink, H. J. L., Mann, J. F. E., Pratley, R., Raz, I., Idorn, T., Rasmussen, S., von Scholten, B. J., et al. (2021) · Diabetes Care
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 71
- Verified
Glucose intolerance in pregnancy and risk of early-onset type 2 diabetes: a population-based cohort study
Bardugo, A., Bendor, C. D., Rotem, R. S., Tsur, A. M., Derazne, E., Gerstein, H. C., Tzur, D., Pinhas-Hamiel, O., Cukierman-Yaffe, T., Raz, I., et al. (2023) · The Lancet Diabetes & Endocrinology
Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 61
- Verified · note
Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial
Zelniker, T. A., Raz, I., Mosenzon, O., Dwyer, J. P., Heerspink, H. H. J. L., Cahn, A., Goodrich, E. L., Im, K., Bhatt, D. L., Leiter, L. A., et al. (2021) · JAMA Cardiology
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 52
- Verified
Safety of liraglutide in type 2 diabetes and chronic kidney disease
Mann, J. F. E., Fonseca, V. A., Poulter, N. R., Raz, I., Idorn, T., Rasmussen, S., von Scholten, B. J., Mosenzon, O., & on behalf of the LEADER Trial Investigators (2020) · Clinical Journal of the American Society of Nephrology
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 50
- Verified
Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic Stenosis
Small, A. M., Melloni, G. E. M., Kamanu, F. K., Bergmark, B. A., Bonaca, M. P., O’Donoghue, M. L., Giugliano, R. P., Scirica, B. M., Bhatt, D., Antman, E. M., et al. (2024) · JAMA Cardiology
Cardiac Valve Diseases and TreatmentsGenetic Associations and Epidemiology
Cited by 23
- Verified
Skeletal muscle glycogen synthase activity in subjects with non-insulin-dependent diabetes mellitus after glyburide therapy
Nyomba, B. L., Freymond, D., Raz, I., Stone, K., Mott, D. M., & Bogardus, C. (1990) · Metabolism
Metabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 17
- Verified
244-OR: Effects of Dapagliflozin on the Urinary Albumin-to-Creatinine Ratio in Patients with Type 2 Diabetes: A Predefined Analysis from the DECLARE-TIMI 58 Randomised, Placebo-Controlled Trial
RAZ, I., WIVIOTT, S. D., YANUV, I., ROZENBERG, A., ZELNIKER, T. A., CAHN, A., HEERSPINK, H. L., DWYER, J. P., GOODRICH, E., BHATT, D. L., et al. (2019) · Diabetes
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 15
- Verified
Machine learning based study of longitudinal HbA1c trends and their association with all-cause mortality: analyses from a national diabetes registry
Cahn, A., Zuker, I., Eilenberg, R., Uziel, M., Tsadok, M. A., Raz, I., & Lutski, M. (2022) · Diabetes/Metabolism Research and Reviews
Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 9
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free